Abstract
DURING wound healing, migrating cells increase expression of both the vitronectin receptor (VNR) integrins1 and plasminogen activators2,3. Here we report that vitronectin significantly enhances the migration of smooth muscle cells (SMCs), and that the specific VNR αvβ3 is required for cell motility. We also show that the αvβ3 attachment site on vitronectin overlaps with the binding site for plasminogen activator inhibitor (PAI)-l, and that the active conformation of PAI-1 blocks SMC migration. This effect requires high-affinity binding to vitronectin, and is not dependent on the ability of PAI-1 to inhibit plasminogen activators. Formation of a complex between PAI-1 and plasminogen activators results in loss of PAI-1 affinity for vitronectin and restores cell migration. These data demonstrate a direct link between plasminogen activators and integrin-mediated cell migration, and show that PAI-1 can control cell–matrix interactions by regulating the accessibility of specific cell-attachment sites. This indicates that the localization of plasminogen activators at sites of focal contact does not initiate a proteolytic cascade leading to generalized matrix destruction, but instead is required to expose cryptic cell-attachment sites necessary for SMC migration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Clark, R. A. F. Tonnesen, M. G., Gailit, J. & Cheresh, D. A. Am. J. Pathol. 148, 1407–1421 (1996).
Pepper, M. S. et al. J. Cell Biol. 122, 673–684 (1993).
Grodahl-Hansen, J., Lund, L. R., Ralfkiaer, E., Ottevanger, V. & Dano, K. J. Invest. Dermatol. 90, 790–795 (1988).
Lauffenburger, D. A. & Horwitz, A. F. Cell 84, 359–369 (1996).
Clark, E. A. & Brugge, J. S. Science 268, 233–239 (1995).
Hannigan, G. E. et al. Nature 379, 91–96 (1996).
Brooks, P. C., Clarck, R. A. F. & Cheresh, D. A. Science 264, 569–571 (1994).
Brooks, P. C. et al. Cell 79, 1157–1164 (1994).
More, R. S., Underwood, M. J., Brack, M. J., de Bono, D. P. & Gershlick, A. H. Cardiovasc. Res. 29, 22–26 (1995).
Ciambrone, G. J. & McKeown-Longo, P. J. J. Biol. Chem. 267, 13617–13622 (1992).
Clyman, R. I., Mauray, F. & Kramer, R. H. Exp. Cell Res. 200, 272–284 (1992).
Carmeliet, P. et al. Fibrinolysis 10, 194 (1996).
Vassalli, J.-D. & Pepper, M. S. Nature 370, 14–15 (1994).
Seiffert, D., Ciambrone, G., Wagner, N. V., Binder, B. R. & Loskutoff, D. J. J. Biol. Chem. 269, 2659–2666 (1994).
Lawrence, D. A., Berkenpas, M. B., Palaniappan, S. & Ginsburg, D. J. Biol. Chem. 269, 15223–15228 (1994).
Shore, J. D. et al. J. Biol. Chem. 270, 5395–5398 (1994).
Lawrence, D. A. et al. J. Biol. Chem. 270, 25309–25312 (1995).
Declerck, P. J. et al. J. Biol. Chem. 263, 15454–15461 (1988).
Stefansson, S., Lawrence, D. A. & Argraves, W. S. J. Biol. Chem. 271, 8215–8220 (1996).
Haas, T. A. & Plow, E. F. Curr. Opin. Cell Biol. 6, 656–662 (1994).
Brown, S. L., Lundgren, C. H., Nordt, T. & Fujii, S. Cardiovasc. Res. 28, 1815–1820 (1994).
Jones, J. I., Prevette, T., Gockerman, A. & Clemmons, D. R. Proc. Natl Acad. Sci. USA 93, 2482–2487 (1996).
Kim, J. P., Zhang, K., Chen, J. D., Kramer, R. H. & Woodley, D. T. J. Biol. Chem. 269, 26926–26932 (1994).
Mimuro, J., Schleef, R. R. & Loskutoff, D. J. Blood 70, 721–728 (1987).
Ehrlich, H. J. et al. J. Biol. Chem. 265, 13029–13035 (1990).
Naski, M. C., Lawrence, D. A., Mosher, D. F., Podor, T. J. & Ginsburg, D. J. Biol. Chem. 268, 12367–12372 (1993).
Pintucci, G. et al. J. Lab. Clin. Med. 122, 69–79 (1993).
Levin, E. G. & Santell, L. J. Cell Biol. 105, 2543–2549 (1987).
Kvassman, J.-O. & Shore, J. D. Fibrinolysis 9, 215–221 (1995).
Smith, J. W. & Cheresh, D. A. J. Biol. Chem. 263, 18726–18731 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stefansson, S., Lawrence, D. The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin. Nature 383, 441–443 (1996). https://doi.org/10.1038/383441a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/383441a0
This article is cited by
-
Galectin-1–Related Modulation of Trophoblast Endothelial Interactions by Integrins α1 and β1
Reproductive Sciences (2020)
-
Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1
Scientific Reports (2019)
-
Astrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword
Molecular Neurobiology (2019)
-
Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression
Cellular and Molecular Life Sciences (2015)
-
Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts
Laboratory Investigation (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.